Unbound Free Fatty Acids from Preterm Infants Treated with Intralipid Decouples Unbound from Total Bilirubin Potentially Making Phototherapy Ineffective

T. Hegyi,S. Kathiravan,G. Stahl,Andrew H. Huber,A. Kleinfeld
DOI: https://doi.org/10.1159/000349995
2013-08-17
Neonatology
Abstract:Extremely low birth weight (ELBW; <1,000 g) infants have poor outcomes, often compromised by bilirubin neurotoxicity. We measured unbound bilirubin (B<sub>f</sub>) and unbound free fatty acid (FFA<sub>u</sub>) levels in 5 ELBW infants in a trial examining the effects of pharmacologic ductal closure on infants treated with Intralipid infusion (3 g/kg/day). The levels for all infants (mean ± SD) were: total serum bilirubin (TSB) 4.6 ± 1.7 mg/dl, FFA<sub>u</sub> 376 ± 496 n<smlcap>M</smlcap>, and B<sub>f</sub> 42 ± 30 n<smlcap>M</smlcap>. Of the 3 infants who died, 2 had TSB <5.9 mg/dl but FFA<sub>u</sub> >580 n<smlcap>M</smlcap> and B<sub>f</sub> >75 n<smlcap>M</smlcap>. Multiple regression revealed a major effect on B<sub>f</sub> levels due to FFA<sub>u</sub>, indicating that Intralipid elevated levels of FFA<sub>u</sub> and B<sub>f</sub>. Indomethacin or ibuprofen reduced B<sub>f</sub> levels, most likely by reducing FFA<sub>u</sub> levels through lipase inhibition. Because displacement of B<sub>f</sub> by FFA<sub>u</sub> decouples B<sub>f</sub> from TSB, phototherapy may not reduce the risk of bilirubin or FFA<sub>u</sub> toxicity in Intralipid-treated ELBW infants.
What problem does this paper attempt to address?